New Сytogenetic Approaches in Patients With Primary Myelofibrosis

Klinicheskaya Onkogematologiya/Clinical Oncohematology - Russian Federation
doi 10.21320/2500-2139-2016-9-1-61-69
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Practical Medicine Publishing House

Related search

New Insight Into the Treatment of Primary Myelofibrosis

Cancer therapy & Oncology International Journal
2018English

Improvement of Anaemia in Patients With Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone

Acta medica (Hradec Kralove)
Medicine
2016English

Canonical WNT/Β-Catenin Signaling Pathway Is Dysregulated in Patients With Primary and Secondary Myelofibrosis

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

A Retrospective Survey of Exposure History to Chemotherapy or Radiotherapy in 940 Consecutive Patients With Primary Myelofibrosis

American Journal of Hematology
Hematology
2018English

SF3B1 Mutations in Primary Myelofibrosis: Clinical, Histopathology and Genetic Correlates Among 155 Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Janus Kinase V617F Mutation Detection in Patients With Myelofibrosis

Balkan Journal of Medical Genetics
Genetics
2019English

Prognosis of Primary Myelofibrosis in the Genomic Era

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

A Phase 2 Study of Simtuzumab in Patients With Primary, Post-Polycythaemia Vera or Post-Essential Thrombocythaemia Myelofibrosis

British Journal of Haematology
Hematology
2017English

Morphologic and Cytogenetic Differences Between Post-Polycythemic Myelofibrosis and Primary Myelofibrosis in Fibrotic Stage

Modern Pathology
Forensic MedicinePathology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy